Change in cardiometabolic risk factors in a pilot safety-net plant-based lifestyle medicine program. (bibtex)
by Stephanie L Albert, Rachel E Massar, Lilian Correa, Lorraine Kwok, Shivam Joshi, Sapana Shah, Rebecca Boas, Héctor E Alcalá and Michelle McMacken
Abstract:
INTRODUCTION: Interventions emphasizing healthful lifestyle behaviors are proliferating in traditional health care settings, yet there is a paucity of published clinical outcomes, outside of pay-out-of-pocket or employee health programs. METHODS: We assessed weight, hemoglobin A1c (HbA1c), blood pressure, and cholesterol for 173 patients of the Plant-Based Lifestyle Medicine Program piloted in a New York City safety-net hospital. We used Wilcoxon signed-rank tests to assess changes in means, from baseline to six-months, for the full sample and within baseline diagnoses (i.e., overweight or obesity, type 2 diabetes, prediabetes, hypertension, hyperlipidemia). We calculated the percentage of patients with clinically meaningful changes in outcomes for the full sample and within diagnoses. FINDINGS: The full sample had statistically significant improvements in weight, HbA1c, and diastolic blood pressure. Patients with prediabetes or overweight or obesity experienced significant improvements in weight and those with type 2 diabetes had significant improvements in weight and HbA1c. Patients with hypertension had significant reductions in diastolic blood pressure and weight. Data did not show differences in non-high-density lipoprotein cholesterol (non-HDL-C), but differences in low-density lipoprotein cholesterol (LDL-C) were approaching significance for the full sample and those with hyperlipidemia. The majority of patients achieved clinically meaningful improvements on all outcomes besides systolic blood pressure. CONCLUSION: Our study demonstrates that a lifestyle medicine intervention within a traditional, safety-net clinical setting improved biomarkers of cardiometabolic disease. Our findings are limited by small sample sizes. Additional large-scale, rigorous studies are needed to further establish the effectiveness of lifestyle medicine interventions in similar settings.
Reference:
Change in cardiometabolic risk factors in a pilot safety-net plant-based lifestyle medicine program. (Stephanie L Albert, Rachel E Massar, Lilian Correa, Lorraine Kwok, Shivam Joshi, Sapana Shah, Rebecca Boas, Héctor E Alcalá and Michelle McMacken), In Front Nutr, volume 10, 2023.
Bibtex Entry:
@article{Albert:2023aa,
	abstract = {INTRODUCTION: Interventions emphasizing healthful lifestyle behaviors are proliferating in traditional health care settings, yet there is a paucity of published clinical outcomes, outside of pay-out-of-pocket or employee health programs. METHODS: We assessed weight, hemoglobin A1c (HbA1c), blood pressure, and cholesterol for 173 patients of the Plant-Based Lifestyle Medicine Program piloted in a New York City safety-net hospital. We used Wilcoxon signed-rank tests to assess changes in means, from baseline to six-months, for the full sample and within baseline diagnoses (i.e., overweight or obesity, type 2 diabetes, prediabetes, hypertension, hyperlipidemia). We calculated the percentage of patients with clinically meaningful changes in outcomes for the full sample and within diagnoses. FINDINGS: The full sample had statistically significant improvements in weight, HbA1c, and diastolic blood pressure. Patients with prediabetes or overweight or obesity experienced significant improvements in weight and those with type 2 diabetes had significant improvements in weight and HbA1c. Patients with hypertension had significant reductions in diastolic blood pressure and weight. Data did not show differences in non-high-density lipoprotein cholesterol (non-HDL-C), but differences in low-density lipoprotein cholesterol (LDL-C) were approaching significance for the full sample and those with hyperlipidemia. The majority of patients achieved clinically meaningful improvements on all outcomes besides systolic blood pressure. CONCLUSION: Our study demonstrates that a lifestyle medicine intervention within a traditional, safety-net clinical setting improved biomarkers of cardiometabolic disease. Our findings are limited by small sample sizes. Additional large-scale, rigorous studies are needed to further establish the effectiveness of lifestyle medicine interventions in similar settings.},
	address = {NYU Grossman School of Medicine, New York, NY, United States.; NYU Grossman School of Medicine, New York, NY, United States.; NYC Health + Hospitals, New York, NY, United States.; NYU Grossman School of Medicine, New York, NY, United States.; NYU Grossman School of Medicine, New York, NY, United States.; Veterans Affairs, Orlando, FL, United States.; NYU Grossman School of Medicine, New York, NY, United States.; NYC Health + Hospitals, New York, NY, United States.; NYU Grossman School of Medicine, New York, NY, United States.; NYC Health + Hospitals, New York, NY, United States.; Department of Behavioral and Community Health, School of Public Health, University of Maryland, College Park, MD, United States.; Program in Oncology, University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD, United States.; NYU Grossman School of Medicine, New York, NY, United States.; NYC Health + Hospitals, New York, NY, United States.},
	author = {Albert, Stephanie L and Massar, Rachel E and Correa, Lilian and Kwok, Lorraine and Joshi, Shivam and Shah, Sapana and Boas, Rebecca and Alcal{\'a}, H{\'e}ctor E and McMacken, Michelle},
	cois = {The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.},
	copyright = {Copyright {\copyright}2023 Albert, Massar, Correa, Kwok, Joshi, Shah, Boas, Alcal{\'a}and McMacken.},
	crdt = {2023/05/08 04:22},
	date = {2023},
	date-added = {2023-05-28 10:21:27 +0100},
	date-modified = {2023-06-03 19:57:13 +0100},
	dep = {20230420},
	doi = {10.3389/fnut.2023.1155817},
	edat = {2023/05/08 06:42},
	issn = {2296-861X (Print); 2296-861X (Electronic); 2296-861X (Linking)},
	jid = {101642264},
	journal = {Front Nutr},
	jt = {Frontiers in nutrition},
	keywords = {Plant-Based Diet; CKD},
	language = {eng},
	lid = {10.3389/fnut.2023.1155817 {$[$}doi{$]$}; 1155817},
	lr = {20230509},
	mhda = {2023/05/08 06:43},
	oto = {NOTNLM},
	own = {NLM},
	pages = {1155817},
	phst = {2023/01/31 00:00 {$[$}received{$]$}; 2023/03/20 00:00 {$[$}accepted{$]$}; 2023/05/08 06:43 {$[$}medline{$]$}; 2023/05/08 06:42 {$[$}pubmed{$]$}; 2023/05/08 04:22 {$[$}entrez{$]$}},
	pl = {Switzerland},
	pmc = {PMC10157493},
	pmid = {37153909},
	pst = {epublish},
	pt = {Journal Article},
	status = {PubMed-not-MEDLINE},
	title = {Change in cardiometabolic risk factors in a pilot safety-net plant-based lifestyle medicine program.},
	volume = {10},
	year = {2023},
	bdsk-url-1 = {https://doi.org/10.3389/fnut.2023.1155817}}
Powered by Portal da Diálise